Move of the month Dr Alison Evans appointed head of education and training at Drug Safety Research Unit
The Drug Safety Research Unit (DSRU) has announced the appointment of Dr Alison Evans as its new head of education and training.
Alison joined the DSRU in 2012 after working as a postdoctoral research fellow at University College London, UK.
She has also worked in the positions of study manager for the Post Authorisation Safety Studies on the anticoagulant rivaroxaban, (ROSE and ROSE ACS) at the DSRU, as well as leading pharmacovigilance studies as a study manager and senior research fellow including the unit’s post-authorisation active surveillance study on the AstraZeneca COVID-19 vaccine.
Professor Saad Shakir, director of the DSRU, stated: “Alison has more than 20 years of experience in conducting complex and vigorous studies into the safety of vaccines and drugs used in healthcare today. Alison will bring a wealth of knowledge and insight to our education and training department that will undoubtedly enhance the programme and allow us to continue to provide informative courses that support delegates to make decisions in their own working environments.”
Commenting on her new role, Dr Alison Evans added: “I am delighted to become the head of Education and Training and will use all of my expertise and resources to enhance the already high-quality programme of courses. The pharmacovigilance landscape is ever changing and so it is important to the DSRU that our courses are designed and delivered by people who are active in the field and know the topics which need to be covered. […] Pharmacovigilance is a rapidly evolving field, which is highly regulated and has high stakes. Giving people the opportunity to have regular training opportunities is vastly important to ensure the work being done in the field is up to date and of the highest quality.”